Synthesis and cytotoxic activities of α-methylidene-γ-butyrolactones bearing a quinolin-4(1H)-one moiety

Helvetica Chimica Acta

Volumn 84, Issue 4, 2001, Pages 874-879

  Hsu, Shu Lin ^a   Chen, Ych Long ^a   Tzeng, Cherng Chyi ^a   Fang, Kuo Chang ^b   Sheu, Jia Yuh ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; CARBOXYLIC ACIDS; CELLS; CONDENSATION; DERIVATIVES; SYNTHESIS (CHEMICAL); TUMORS;

CYTOTOXIC;

ORGANIC COMPOUNDS;

1 ETHYL 6 FLUORO 1,4 DIHYDRO 7 (2 METHYL 5 OXAZOLYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID; ALPHA METHYLIDENE GAMMA BUTYROLACTONE DERIVATIVE; GAMMA BUTYROLACTONE DERIVATIVE; PIPERAZINE DERIVATIVE; QUINOLIN 4(1H) ONE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOM; CANCER CELL; CYTOTOXICITY; GROWTH INHIBITION; LEUKEMIA; SYNTHESIS; TUMOR CELL;

EID: 0035051908     PISSN: 0018019X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2675(20010418)84:4<874::AID-HLCA874>3.0.CO;2-I     Document Type: Article

References (36)

1. K. H. Lee, I. H. Hall, E. C. Mar, C. O. Starnes, S. A. Elgebaly, T. G. Waddell, R. I. Hadgraft, C. G. Ruffner, I. Weidner, Science (Washington, D.C.) 1977, 196, 533.
2. N. Petragnani, H. M. C. Ferraz, G. V. J. Silva, Synthesis 1986, 157.
3. H. M. R. Hoffmann, J. Rabe, Angew. Chem., Int. Ed. 1985, 24, 94.
4. O. Spring, K. Albert, W. Gradmann, Phytochemistry 1981, 20, 1883;
5. N. H. Fischer, T. Lu, C. L. Cantrell, J. Castaneda-Acosta, L. Quliano, S. Franzblau, Phytochemistry 1998, 49, 559;
6. Y. Fukushi, C. Yajima, J. Mizutani, S. Tahara, Phytochemistry 1998, 49, 593;
7. A. Ortega, R. A. Toscano, E. Maldonado, Phytochemistry 1998, 49, 1085.
8. I. S. Chen, I. L. Lai-Yuan, C. Y. Duh, I. L. Tsai, Phytochemistry 1998, 49, 745.
9. C. J. Cavallito, T. H. Haskell, J. Am. Chem. Soc. 1946, 68, 2332;
10. M. T. Gette, J. E. J. James, Arch. Dermatol. 1990, 126, 203;
11. A. Slob, Phytochemistry 1973, 12, 811;
12. M. W. I. C. van Rossum, M. Alberda, L. H. W. van der Plas, Phytochemistry 1998, 49, 723.
13. Y. L. Chen, T. C. Wang, K. H. Lee, Y. L. Chang, C. M. Teng, C. C. Tzeng, Helv. Chim. Acta 1996, 79, 651;
14. Y. L. Chen, T. C. Wang, S. C. Liang, C. M. Teng, C. C. Tzeng, Chem. Pharm. Bull. 1996, 44, 1591;
15. T. C. Wang, Y. L. Chen, S. S. Liou, Y. L. Chang, C. M. Teng, C. C. Tzeng, Helv. Chim. Acta 1996, 79, 1620;
16. C. C. Tzeng, Y. L. Zhao, Y. L. Chen, S. S. Liou, T. C. Wang, Y. L. Chang, C. M. Teng, Helv. Chim. Acta 1997, 80, 2337;
17. C. H. Liao, C. C. Tzeng, C. M. Teng, Eur. J. Pharmacol 1998, 349, 107;
18. Y. L. Zhao, T. C. Wang, Y. L. Chen, Y. L. Chang, C. M. Teng, C. C. Tzeng, Chin. Pharm. J. 1999, 51, 49;
19. T. C. Wang, K. H. Lee, Y. L. Chen, S. S. Liou, C. C. Tzeng, Bioorg. Med. Chem. Lett. 1998, 8, 2773;
20. Y. L. Chen, T. C. Wang, N. C. Chang, C. C. Tzeng, Helv. Chim. Acta 1999, 82, 191;
21. K. H. Lee, B. R. Huang, C. C. Tzeng, Bioorg. Med. Chem. Lett. 1999, 9, 241;
22. Y. L. Chen, I. L. Chen, C. C. Tzeng, T. C. Wang, Helv. Chim. Acta 2000, 83, 989.
23. C. C. Tzeng, T. C. Wang, Y. L. Chen, C. J. Wang, Y. L. Chang, C. M. Teng, Helv. Chim. Acta 1997, 80, 1161;
24. T. C. Wang, Y. L. Chen, S. S. Liou, W. F. Tzeng, Y. L. Chang, C. U. Teng, C. C. Tzeng, Helv. Chim. Acta 1998, 81, 1038;
25. Y. L. Chen, T. C. Wang, K. C. Fang, N. C. Chang, C. C. Tzeng, Heterocycles 1999, 50, 453;
26. C. C. Tzeng, I. L. Chen, Y. L. Chen, T. C. Wang, Y. L. Chang, C. M. Teng, Helv. Chim. Acta 2000, 83, 349.
27. S. M. Kupchan, D. C. Fessler, M. A. Eakin, T. J. Giacobbe, Science (Washington, D.C.) 1970, 168, 376.
28. K. C. Fang, Y. L. Chen, J. Y. Sheu, T. C. Wang, C. C. Tzeng, J. Med. Chem. 2000, 43, 3809.
29. L. L. Shen, J. Baranowski, A. G. Pernet, Biochemistry 1989, 28, 3879.
30. L. L. Shen, W. E. Kohlbrenner, D. Weigl, J. Baronowski, J. Biol. Chem. 1989, 264, 2973.
31. J. F. Barrett, J. A. Sutcliffe, T. D. Gootz, Antimicrob. Agents Chemother. 1990, 34, 1.
32. M. P. Wentland, G. Y. Lesher, M. Reuman, M. D. Gruett, B. Sinf, S. C. Aldous, P. H. Dorff, J. B. Rake, S. A. Coughlin, J. Med. Chem. 1993, 56, 2801.
33. J. J. Clement, N. Burres, K. Jarvis, D. T. W. Chu, J. Swinirski, J. Alder, Cancer Res. 1995, 55, 830.
34. C. B. Ziegler, W. V. Curran, N. A. Kuck, S. M. Harris, Y. I. Lin, J. Heterocycl. Chem. 1989, 26, 1141.
35. A. Monks, D. Scuderio, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langlay, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, M. Boyd, J. Natl. Cancer Inst. 1991, 83, 757.
36. J. Plowman, D. J. Dykes, M. Hollingshead, L. Simpson-Herren, M. C. Alley, 'Human Tumor Xenograft Models in NCI Drug Development', in 'Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval', Ed. B. Teicher, Humana Press, Inc., Totowa, N.J., 1997, p. 101.